159 related articles for article (PubMed ID: 26535588)
1. Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study.
Nishijima T; Hayashida T; Kurosawa T; Tanaka N; Oka S; Gatanaga H
PLoS One; 2015; 10(11):e0141931. PubMed ID: 26535588
[TBL] [Abstract][Full Text] [Related]
2. A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection.
Likanonsakul S; Suntisuklappon B; Nitiyanontakij R; Prasithsirikul W; Nakayama EE; Shioda T; Sangsajja C
PLoS One; 2016; 11(1):e0147724. PubMed ID: 26807589
[TBL] [Abstract][Full Text] [Related]
3. ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen.
Manosuthi W; Sukasem C; Thongyen S; Nilkamhang S; Sungkanuparph S
J Antimicrob Chemother; 2014 Aug; 69(8):2195-201. PubMed ID: 24788661
[TBL] [Abstract][Full Text] [Related]
4. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients.
Huang YS; Chan CK; Tsai MS; Lee KY; Lin SW; Chang SY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2017 Oct; 50(5):595-603. PubMed ID: 26514942
[TBL] [Abstract][Full Text] [Related]
5. Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up.
Nishijima T; Kawasaki Y; Tanaka N; Mizushima D; Aoki T; Watanabe K; Kinai E; Honda H; Yazaki H; Tanuma J; Tsukada K; Teruya K; Kikuchi Y; Gatanaga H; Oka S
AIDS; 2014 Aug; 28(13):1903-10. PubMed ID: 25259702
[TBL] [Abstract][Full Text] [Related]
6. Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy.
Nishijima T; Kurosawa T; Tanaka N; Kawasaki Y; Kikuchi Y; Oka S; Gatanaga H
AIDS; 2016 Jun; 30(10):1563-71. PubMed ID: 26919734
[TBL] [Abstract][Full Text] [Related]
7. Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific.
Tanuma J; Jiamsakul A; Makane A; Avihingsanon A; Ng OT; Kiertiburanakul S; Chaiwarith R; Kumarasamy N; Nguyen KV; Pham TT; Lee MP; Ditangco R; Merati TP; Choi JY; Wong WW; Kamarulzaman A; Yunihastuti E; Sim BL; Ratanasuwan W; Kantipong P; Zhang F; Mustafa M; Saphonn V; Pujari S; Sohn AH;
PLoS One; 2016; 11(8):e0161562. PubMed ID: 27560968
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients.
Cusato J; Calcagno A; Marinaro L; Avataneo V; DʹAvolio A; Di Perri G; Bonora S
Pharmacogenomics J; 2020 Apr; 20(2):202-212. PubMed ID: 31619748
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study.
Nishijima T; Komatsu H; Higasa K; Takano M; Tsuchiya K; Hayashida T; Oka S; Gatanaga H
Clin Infect Dis; 2012 Dec; 55(11):1558-67. PubMed ID: 22955427
[TBL] [Abstract][Full Text] [Related]
10. Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir.
Yilma D; Abdissa A; Kæstel P; Tesfaye M; Olsen MF; Girma T; Ritz C; Friis H; Andersen ÅB; Kirk O
BMC Infect Dis; 2020 Aug; 20(1):582. PubMed ID: 32762646
[TBL] [Abstract][Full Text] [Related]
11. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.
Izzedine H; Hulot JS; Villard E; Goyenvalle C; Dominguez S; Ghosn J; Valantin MA; Lechat P; Deray AG
J Infect Dis; 2006 Dec; 194(11):1481-91. PubMed ID: 17083032
[TBL] [Abstract][Full Text] [Related]
12. Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.
Suzuki S; Nishijima T; Kawasaki Y; Kurosawa T; Mutoh Y; Kikuchi Y; Gatanaga H; Oka S
AIDS Patient Care STDS; 2017 Mar; 31(3):105-112. PubMed ID: 28282247
[TBL] [Abstract][Full Text] [Related]
13. Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting.
Milazzo L; Gervasoni C; Falvella FS; Cattaneo D; Mazzali C; Ronzi P; Binda F; Cheli S; Sollima S; Antinori S
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):191-196. PubMed ID: 27809359
[TBL] [Abstract][Full Text] [Related]
14. A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome.
Dahlin A; Wittwer M; de la Cruz M; Woo JM; Bam R; Scharen-Guivel V; Flaherty J; Ray AS; Cihlar T; Gupta SK; Giacomini KM
Pharmacogenet Genomics; 2015 Feb; 25(2):82-92. PubMed ID: 25485598
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients.
Salvaggio SE; Giacomelli A; Falvella FS; Oreni ML; Meraviglia P; Atzori C; Clementi EGI; Galli M; Rusconi S
BMC Infect Dis; 2017 Jun; 17(1):396. PubMed ID: 28583112
[TBL] [Abstract][Full Text] [Related]
16. Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?
Marcelin JR; Berg ML; Tan EM; Amer H; Cummins NW; Rizza SA
PLoS One; 2016; 11(2):e0149562. PubMed ID: 26872144
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms associated with renal adverse effects of antiretroviral therapy in a Southern Brazilian HIV cohort.
da Rocha IM; Gasparotto AS; Lazzaretti RK; Notti RK; Sprinz E; Mattevi VS
Pharmacogenet Genomics; 2015 Nov; 25(11):541-7. PubMed ID: 26287941
[TBL] [Abstract][Full Text] [Related]
18. Renal Toxicity of Concomitant Exposure to Tenofovir and Inhibitors of Tenofovir's Renal Efflux Transporters in Patients Infected With HIV Type 1.
Rokx C; Alshangi H; Verbon A; Zietse R; Hoorn EJ; Rijnders BJ
J Infect Dis; 2016 Feb; 213(4):561-8. PubMed ID: 26401025
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of tenofovir treatment.
Rodriguez-Novoa S; Labarga P; Soriano V
Pharmacogenomics; 2009 Oct; 10(10):1675-85. PubMed ID: 19842939
[TBL] [Abstract][Full Text] [Related]
20. Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.
Rodríguez-Nóvoa S; Labarga P; Soriano V; Egan D; Albalater M; Morello J; Cuenca L; González-Pardo G; Khoo S; Back D; Owen A
Clin Infect Dis; 2009 Jun; 48(11):e108-16. PubMed ID: 19400747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]